Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea.
Cheng, Jocelyn Y; Lorch, Daniel; Lowe, Alan D; Uchimura, Naohisa; Hall, Nancy; Shah, Dhara; Moline, Margaret.
Affiliation
  • Cheng JY; Eisai Inc., Nutley, New Jersey.
  • Lorch D; Teradan Clinical Trials LLC, Brandon, Florida.
  • Lowe AD; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Uchimura N; Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan.
  • Hall N; Eisai Inc., Nutley, New Jersey.
  • Shah D; Eisai Inc., Nutley, New Jersey.
  • Moline M; Eisai Inc., Nutley, New Jersey.
J Clin Sleep Med ; 20(1): 57-65, 2024 Jan 01.
Article in En | MEDLINE | ID: mdl-37677076

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Sleep Apnea, Obstructive Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: J Clin Sleep Med Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Sleep Apnea, Obstructive Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: J Clin Sleep Med Year: 2024 Document type: Article